Funder: Cancer Research UK
Due Dates: October 2, 2025 (Outline) | February 19, 2026 (Full, by invitation) | March 26, 2026 (Outline)
Funding Amounts: Up to £1.75 million over 6 years (non-renewable); typically supports PI salary (50%), staff, running costs, equipment, and relocation.
Summary: Supports established group leaders to develop ambitious, independent cancer research programmes and become world leaders in the field.
Key Information: Clinicians will become ineligible after the May 2026 review; host institution must contribute 50% of PI salary and guarantee a long-term position.